Free Newsletter
Suicide stats fuel debate over SSRI drugs
The unintended consequences of managing SSRI drugs can be severe, according to a new federally-funded study of suicidal behavior among children. In 2003, the feds warned that the widely used antidepressants might increase the risk of suicide among the under-19 crowd. Not surprisingly, kid-sized prescriptions for Prozac and its ilk dropped.
But then the unforeseen happened. Suicides in that age group actually escalated by 14 percent from 2003 to 2004. That's a dramatic change in just one year--the most dramatic since the government started keeping those stats in 1979. There's no proof that a fall-off in antidepressant use caused the increase in suicides, but the study authors say few other explanations present themselves. And statistics show that, among population subgroups where antidepressant use is highest, suicides are lowest.
SSRI critics have other ideas, namely the increased use of antipsychotics among children. No doubt the debate will continue.
- check out the report from the Washington Post
Related Articles:
U.K. demands all SSRI data
Study: Antidepressants useless for most
FDA orders new warnings for antidepressants
Child suicide rise tied to FDA warnings
Antidepressants--Top 10 Warnings and Recalls of 2007
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





